The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism
Abstract
Objectives: The use of doxorubicin, a drug utilised for many years to treat a wide variety of cancers, has long been limited due to the significant toxicity that can occur not only during, but also years after treatment. It has multiple mechanisms of action including the intercalation of DNA, inhibition of topoisomerase II and the production of free radicals. We review the literature, with the aim of highlighting the role of drug concentration being an important determinant on the unfolding cell biological events that lead to cell stasis or death. Methods: The PubMed database was consulted to compile this review. Key findings: It has been found that the various mechanisms of action at the disposal of doxorubicin culminate in either cell death or cell growth arrest through various cell biological events, such as apoptosis, autophagy, senescence and necrosis. Which of these events is the eventual cause of cell death or growth arrest appears to vary depending on factors such as the patient, cell and cancer type, doxorubicin concentration and the duration of treatment. Conclusions: Further understanding of doxorubicin's influence on cell biological events could lead to an improvement in the drug's efficacy and reduce toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Self-citationGewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Mitochondrial form and function
Friedman, J. R., & Nunnari, J. (2014) · Nature · doi:10.1038/nature12985 · Cited by 1,803
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Doxorubicin: The good, the bad and the ugly effect
Carvalho, C., Santos, R., Cardoso, S., Correia, S., Oliveira, P., Santos, M., & Moreira, P. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803312 · Cited by 1,509 · cited 1×
“It is often used to treat acute leukaemia,([3]) breast cancer([4]) and childhood solid tumours,([5]) non-Hodgkin lymphomas,([6]) Hodgkin’s disease([7]) and soft tissue sarcomas.([8]) Unfortunately, despite being highly effective, doxorubicin is also nonselective to cancer cells, so its use is significantly limited due…”
BackgroundDeath by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
DNA and its associated processes as targets for cancer therapy
Hurley, L. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc749 · Cited by 1,349
Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010) · Cardiology · doi:10.1159/000265166 · Cited by 1,065
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 878
Apoptosis, autophagy, and more
Lockshin, R. A., & Zakeri, Z. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.011 · Cited by 700
Alkylating DNA damage stimulates a regulated form of necrotic cell death
Zong, W.-X., Ditsworth, D., Bauer, D. E., Wang, Z.-Q., & Thompson, C. B. (2004) · Genes & Development · doi:10.1101/gad.1199904 · Cited by 618
Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity
Keizer, H. G., Pinedo, H. M., Schuurhuis, G. J., & Joenje, H. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90088-j · Cited by 517
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide
Mizutani, H., Tada-Oikawa, S., Hiraku, Y., Kojima, M., & Kawanishi, S. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.05.040 · Cited by 472
MAPK/JNK signalling: a potential autophagy regulation pathway
Zhou, Y.-Y., Li, Y., Jiang, W.-Q., & Zhou, L.-F. (2015) · Bioscience Reports · doi:10.1042/bsr20140141 · Cited by 444
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
Ashkenazi, A. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2637 · Cited by 432
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Zhang, Y.-W., Shi, J., Li, Y.-J., & Wei, L. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0051-8 · Cited by 387
Investigating the biological functions of DNA topoisomerases in eukaryotic cells
Nitiss, J. L. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00128-6 · Cited by 321
Jia, G., Cheng, G., Gangahar, D. M., & Agrawal, D. K. (2006) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2006.01454.x · Cited by 299
WANG, S., KOTAMRAJU, S., KONOREV, E., KALIVENDI, S., JOSEPH, J., & KALYANARAMAN, B. (2002) · Biochemical Journal · doi:10.1042/bj20020752 · Cited by 286
Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation
Gewirtz, D. A., Holt, S. E., & Elmore, L. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.024 · Cited by 281
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
Elmore, L. W., Rehder, C. W., Di, X., McChesney, P. A., Jackson-Cook, C. K., Gewirtz, D. A., & Holt, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205477200 · Cited by 271
Deffie, A. M., Batra, J. K., & Goldenberg, G. J. (1989) · PubMed · Cited by 261
Autophagy regulates the processing of amino terminal huntingtin fragments
Qin, Z.-H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg346 · Cited by 254
ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy
Rodríguez-Vargas, J. M., Ruiz-Magaña, M. J., Ruiz-Ruiz, C., Majuelos-Melguizo, J., Peralta-Leal, A., Rodríguez, M. I., Muñoz-Gámez, J. A., de Almodóvar, M. R., Siles, E., Rivas, A. L., et al. (2012) · Cell Research · doi:10.1038/cr.2012.70 · Cited by 250
Kuznetsov, A. V., & Margreiter, R. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041911 · Cited by 241
Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review
Aubel-Sadron, G., & Londos-Gagliardi, D. (1984) · Biochimie · doi:10.1016/0300-9084(84)90018-x · Cited by 233
Maejima, Y., Adachi, S., Ito, H., Hirao, K., & Isobe, M. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00358.x · Cited by 224
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
Wallace, K. B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0008-2 · Cited by 221
Wallace, D. C. (2006) · The FASEB Journal · doi:10.1096/fasebj.20.5.a1474-c · Cited by 211
Kalivendi, S. V., Konorev, E. A., Cunningham, S., Vanamala, S. K., Kaji, E. H., Joseph, J., & Kalyanaraman, B. (2005) · Biochemical Journal · doi:10.1042/bj20050285 · Cited by 205
Caspase inhibition switches doxorubicin-induced apoptosis to senescence
Rebbaa, A., Zheng, X., Chou, P. M., & Mirkin, B. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206366 · Cited by 201
Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells
Skladanowski, A., & Konopa, J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90512-u · Cited by 189
Autophagy in disease: a double-edged sword with therapeutic potential
Martinet, W., Agostinis, P., Vanhoecke, B., Dewaele, M., & de Meyer, G. R. Y. (2009) · Clinical Science · doi:10.1042/cs20080508 · Cited by 186
Liu, Y. (2001) · Carcinogenesis · doi:10.1093/carcin/22.6.851 · Cited by 184
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy
Batist, G., Barton, J., Chaikin, P., Swenson, C., & Welles, L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.12.1739 · Cited by 179
Patel, N., Joseph, C., Corcoran, G. B., & Ray, S. D. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.02.002 · Cited by 168
Autophagy in DNA Damage Response
Czarny, P., Pawlowska, E., Bialkowska-Warzecha, J., Kaarniranta, K., & Blasiak, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16022641 · Cited by 165
Programmed necrosis and necroptosis signalling
Feoktistova, M., & Leverkus, M. (2014) · FEBS Journal · doi:10.1111/febs.13120 · Cited by 162
The Autophagy-Senescence Connection in Chemotherapy: Must Tumor Cells (Self) Eat Before They Sleep?
Goehe, R. W., Di, X. M., Sharma, K., Bristol, M. L., Henderson, S. C., Valerie, K. C., Rodier, F., Davalos, A. R., & Gewirtz, D. A. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.197590 · Cited by 145
Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle
Smuder, A. J., Kavazis, A. N., Min, K., & Powers, S. K. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00429.2011 · Cited by 134
Thandavarayan, R. A., Giridharan, V. V., Arumugam, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119214 · Cited by 127
When apoptosis meets autophagy: deciding cell fate after trauma and sepsis
Hsieh, Y., Athar, M., & Chaudry, I. H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.002 · Cited by 121
Hrelia, S., Fiorentini, D., Maraldi, T., Angeloni, C., Bordoni, A., Biagi, P. L., & Hakim, G. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00612-0 · Cited by 120
Chen, M., Wu, X., Gu, J., Guo, Q.-T., Shen, W., & Lu, P. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9153-0 · Cited by 116
Disruption of Mitochondrial Calcium Homeostasis Following Chronic Doxorubicin Administration
Solem, L. E., Henry, T. R., & Wallace, K. B. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1246 · Cited by 116
Role of mtDNA lesions in anthracycline cardiotoxicity
Lebrecht, D., & Walker, U. A. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0009-1 · Cited by 115
Shin, H., Kwon, H., Lee, J.-H., Gui, X., Achek, A., Kim, J. H., & Choi, S. (2015) · Scientific Reports · doi:10.1038/srep15798 · Cited by 111
Marina, N. M., Cochrane, D., Harney, E., Zomorodi, K., Blaney, S. M., Winick, N. J., Bernstein, M. L., & Link, M. P. (2002) · PubMed · Cited by 101
Dong, Z., Wang, L., Xu, J., et al. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.11.003 · Cited by 97
Chen, N., Wu, C., Chung, C., Hwu, Y., Cheng, S., Mou, C., & Lo, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044947 · Cited by 94
Wang, Z., Wang, J., Xie, R., Liu, R., & Lu, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511087 · Cited by 92
Lahoti, T. S., Patel, D., Thekkemadom, V., et al. (2012) · Current Neurovascular Research · doi:10.2174/156720212803530636 · Cited by 92
Averill‐Bates, D. A., & Winterbourn, C. C. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81222-2 · Cited by 91
Di, X. M., Shiu, R. P. C., Newsham, I., & Gewirtz, D. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.016 · Cited by 78
Kim, D., Woo, E., Chae, S., Ha, K.-C., Lee, G., Hong, S., Kwon, D., Kim, M., Jung, Y., Kim, H., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.019 · Cited by 60
Ascensão, A. A. M. R., Oliveira, P. J., & Magalhães, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.060 · Cited by 60
Adriamycin-induced lipid peroxidation in mitochondria and microsomes
Griffin-Green, E. A., Zaleska, M. M., & Erecińska, M. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90303-6 · Cited by 60
Ruggiero, A., Rosa, G. D., Rizzo, D., Leo, A., Maurizi, P., Nisco, A. D., Vendittelli, F., Zuppi, C., Mordente, A., & Riccardi, R. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0458-9 · Cited by 58
Mechanism of the Inhibition of Calf Thymus DNA Polymerases α and β by Daunomycin and Adriamycin1
Tanaka, M., & Yoshida, S. (1980) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132821 · Cited by 47
In vivo prevention of adriamycin cardiotoxicity by cyclosporin A or FK506
Al-Nasser, I. A. (1998) · Toxicology · doi:10.1016/s0300-483x(98)00128-0 · Cited by 28
Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells.
Wang, H., Chang-qing, L., Tan, Y. Q., Xie, J., & Jiang, J. (2014) · PubMed · Cited by 10
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 294
Norouzi, M., Yathindranath, V., Thliveris, J. A., Kopec, B. M., Siahaan, T. J., & Miller, D. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-68017-y · Cited by 292
Metadata
- Authors
- Meredith, A.-M., & Dass, C. R.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-01
- Volume
- 68
- Issue
- 6
- Pages
- 729-741
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2301188205
- Cited by
- 303
- References
- 67
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.